Research & Development
-
Research Pipeline
Improving patient outcomes is the goal of all research at Lilly Research Laboratories. To achieve this goal, LRL has built one of the best mid-stage pipelines in the industry with approximately four dozen distinct compounds in clinical development, including 17 priority biotech and small-molecule candidates, all aimed at improving the lives of patients around the globe.
Discovering New Drugs
Lilly is among the industry's leaders in investing in research and development. The process of discovering, testing and developing a new drug is complex, costly, and time-consuming — costing $800 million or more and spanning 10 to 15 years. In recent years, we have taken steps to accelerate the development of our medicines so that they can reach patients faster.
